Fosun Pharma's controlling shareholder pledges additional shares

Shanghai Fosun Pharmaceutical Group announced today that its controlling shareholder, Fosun High Technology, has pledged an additional 30 million A-shares, bringing the total number of pledged shares to 708.3 million, accounting for 26.51% of the company's total share capital as of March 26, 2025. Fosun High Technology and its consistent actors, including the company’s actual controllers, now have 73.19% of their shareholdings pledged. Fosun High Technology stated the pledge is for debt repayment and that its operations remain normal with sufficient funds to cover the obligations. The pledged shares do not involve any earnings compensation or guarantee arrangements. Fosun Pharma stated it will continue to monitor the pledge's status and fulfill disclosure obligations.